Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos

GE17-5478-01

Capto L

Cytiva 17-5478-01, pack of 25 mL

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
41106500
NACRES:
NA.56

ligand

recombinant protein L (E. coli), mammalian free

embalagem

pack of 25 mL

fabricante/nome comercial

Cytiva 17-5478-01

condição de armazenamento

(20% Ehtanol)

matriz

rigid, highly cross-linked agarose

Tamanho médio da partícula

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

working range

2-10(pH interval where the medium can be operated without significant change in function.)

adequação

suitable for bioprocess medium

temperatura de armazenamento

2-8°C

Descrição geral

Capto L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.

Affinity resin for antibody fragment purification

Capto L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains. The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.

Using this protein L resin

Capto L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.

Aplicação

Purification of antibody fragments using affinity chromatography

Características e benefícios

  • Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
  • High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
  • Enables a platform approach to antibody fragment purification.
  • Excellent productivity, process economy, and process design flexibility due to rigid matrix.
  • Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
  • Fulfills industrial demands for security of supply, robust performance, and regulatory support.

Armazenamento e estabilidade

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Nota de análise

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Informações legais

Capto is a trademark of Cytiva

Pictogramas

Flame

Palavra indicadora

Warning

Frases de perigo

Código de classe de armazenamento

3 - Flammable liquids


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 3

1 of 3

Capto™ adhere Cytiva 17-5444-10, pack of 25 mL

GE17-5444-10

Capto adhere

Capto™ Q Cytiva 17-5316-10, pack of 25 mL

GE17-5316-10

Capto Q

Protocolos

This page shows how to purify antibody fragments by affinity chromatography using Capto L products from Cytiva.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica